NASDAQ: MDCX
Medicus Pharma Ltd Stock

$4.20+0.19 (+4.74%)
Updated Apr 30, 2025
MDCX Price
$4.20
Fair Value Price
$0.40
Market Cap
$56.40M
52 Week Low
$1.80
52 Week High
$4.99
P/E
-3.62x
P/B
17.99x
P/S
N/A
PEG
N/A
Dividend Yield
N/A
Revenue
$0.00
Earnings
-$11.16M
Gross Margin
N/A
Operating Margin
N/A
Profit Margin
N/A
Debt to Equity
0.8
Operating Cash Flow
-$10M
Beta
0.56
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A

MDCX Overview

Medicus Pharma Ltd. is a biotech/life sciences company focused on accelerating the clinical development programs of novel and disruptive therapeutic assets, with an emphasis on non-invasive treatments for skin cancer.

Zen Rating

Our proven quant model uses 115 proprietary factors, including AI, to determine MDCX's potential to beat the market

CHold
  • Stocks with a Zen Rating of Hold (C) had an average return of +7.53% per year. Learn More

Zen Rating Component Grades

C
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.

Industry: Biotech

Industry Rating
F
MDCX
Ranked
#108 of 462

Top Ranked Stocks in Industry

View Top Biotech Stocks

Be the first to know about important MDCX news, forecast changes, insider trades & much more!

MDCX News

Overview

Due Diligence Score

Industry Average (24)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how MDCX scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

MDCX ($4.20) is overvalued by 952.54% relative to our estimate of its Fair Value price of $0.40 based on Discounted Cash Flow (DCF) modelling
Below Fair Value Valuation
MDCX ($4.20) is not significantly undervalued (952.54%) relative to our estimate of its Fair Value price of $0.40 based on Discounted Cash Flow (DCF) modelling, when including a healthy margin of safety
Significantly Below Fair Value Valuation
MDCX is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
There are 30 more MDCX due diligence checks available for Premium users.

Valuation

MDCX fair value

Fair Value of MDCX stock based on Discounted Cash Flow (DCF)

Price
$4.20
Fair Value
$0.40
Overvalued by
951.54%
MDCX ($4.20) is overvalued by... subscribe to Premium to read more.
Below Fair Value Valuation
MDCX ($4.20) is not significantly... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
MDCX is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation

MDCX price to earnings (PE)

For valuing profitable companies with steady earnings

Company
-3.62x
Industry
-162.28x
Market
29.18x

MDCX price to book (PB)

For valuing companies that are loss-making or have lots of physical asset

Company
17.99x
Industry
4.45x
MDCX is poor value based... subscribe to Premium to read more.
P/B vs Industry Valuation

MDCX's financial health

Profit margin

Revenue
$0.0
Net Income
-$2.3M
Profit Margin
0%
MDCX's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials

Assets to liabilities

Assets
$5.6M
Liabilities
$2.5M
Debt to equity
0.8
MDCX's short-term assets ($5.38M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
MDCX's short-term assets ($5.38M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
MDCX's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
-$3.3M
Investing
$0.0
Financing
$2.1M
MDCX's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials

MDCX vs Biotech Stocks

TickerZen RatingMarket Cap1d %P/EP/B
MDCXC$56.40M+4.84%-3.62x17.99x
KPTIF$56.81M+6.30%-0.71x-0.31x
GANXD$56.96M+9.04%-2.30x7.76x
RENB$57.14M+6.51%-0.40x0.58x
ARMP$57.53M+3.92%-3.06x-1.20x

Medicus Pharma Stock FAQ

What is Medicus Pharma's quote symbol?

(NASDAQ: MDCX) Medicus Pharma trades on the NASDAQ under the ticker symbol MDCX. Medicus Pharma stock quotes can also be displayed as NASDAQ: MDCX.

If you're new to stock investing, here's how to buy Medicus Pharma stock.

What is the 52 week high and low for Medicus Pharma (NASDAQ: MDCX)?

(NASDAQ: MDCX) Medicus Pharma's 52-week high was $4.99, and its 52-week low was $1.80. It is currently -15.75% from its 52-week high and 133.56% from its 52-week low.

How much is Medicus Pharma's stock price per share?

(NASDAQ: MDCX) Medicus Pharma stock price per share is $4.20 today (as of Apr 30, 2025).

What is Medicus Pharma's Market Cap?

(NASDAQ: MDCX) Medicus Pharma's market cap is $56.40M, as of May 1, 2025.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Medicus Pharma's market cap is calculated by multiplying MDCX's current stock price of $4.20 by MDCX's total outstanding shares of 13,414,801.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.